TC Biopharm (Holdings) PLCNASDAQ:TCBP
- LAST PRICE0.6260
- TODAY'S CHANGE (%)-0.0040 (-0.6351%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.6098 / 0.6300
- Day Range
- 52 Week Range
- Volume446,759
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TCBP |
|---|---|---|
| 09:32 ET | 18575 | 0.6403 |
| 09:33 ET | 1510 | 0.62 |
| 09:35 ET | 1384 | 0.6199 |
| 09:37 ET | 8711 | 0.61515 |
| 09:39 ET | 2900 | 0.61 |
| 09:42 ET | 301 | 0.6099 |
| 09:46 ET | 2334 | 0.61 |
| 09:48 ET | 100 | 0.605 |
| 09:50 ET | 360 | 0.6039 |
| 09:51 ET | 850 | 0.6 |
| 09:53 ET | 17924 | 0.6 |
| 09:57 ET | 300 | 0.6 |
| 10:00 ET | 340 | 0.6015 |
| 10:02 ET | 11551 | 0.591 |
| 10:04 ET | 2800 | 0.593129 |
| 10:06 ET | 1494 | 0.59599 |
| 10:09 ET | 450 | 0.596 |
| 10:13 ET | 1510 | 0.609999 |
| 10:15 ET | 396 | 0.61 |
| 10:22 ET | 100 | 0.608361 |
| 10:24 ET | 100 | 0.6084 |
| 10:26 ET | 550 | 0.6077 |
| 10:31 ET | 2600 | 0.6059 |
| 10:33 ET | 127 | 0.6 |
| 10:36 ET | 200 | 0.600951 |
| 10:38 ET | 439 | 0.6009 |
| 10:40 ET | 500 | 0.6009 |
| 10:44 ET | 3717 | 0.6 |
| 10:45 ET | 4900 | 0.596 |
| 10:47 ET | 712 | 0.596 |
| 10:49 ET | 406 | 0.596 |
| 10:56 ET | 100 | 0.5925 |
| 11:03 ET | 150 | 0.609899 |
| 11:07 ET | 555 | 0.6099 |
| 11:09 ET | 10468 | 0.6189 |
| 11:12 ET | 2210 | 0.6189 |
| 11:14 ET | 6155 | 0.619899 |
| 11:20 ET | 3744 | 0.613951 |
| 11:27 ET | 580 | 0.61 |
| 11:30 ET | 21852 | 0.63 |
| 11:34 ET | 300 | 0.615 |
| 11:36 ET | 300 | 0.63 |
| 11:38 ET | 2390 | 0.6225 |
| 11:43 ET | 11846 | 0.63 |
| 11:45 ET | 21258 | 0.631 |
| 11:48 ET | 12972 | 0.634949 |
| 11:56 ET | 212 | 0.635 |
| 11:57 ET | 100 | 0.630001 |
| 11:59 ET | 674 | 0.62501 |
| 12:08 ET | 2900 | 0.63 |
| 12:12 ET | 800 | 0.625 |
| 12:17 ET | 1103 | 0.635 |
| 12:21 ET | 154 | 0.625001 |
| 12:24 ET | 500 | 0.635 |
| 12:26 ET | 200 | 0.625 |
| 12:28 ET | 12463 | 0.625 |
| 12:30 ET | 1777 | 0.625 |
| 12:33 ET | 1462 | 0.635 |
| 12:35 ET | 1535 | 0.6344 |
| 12:46 ET | 4800 | 0.6389 |
| 12:48 ET | 2750 | 0.636449 |
| 12:50 ET | 3180 | 0.6384 |
| 12:51 ET | 987 | 0.6384 |
| 12:53 ET | 6250 | 0.6251 |
| 12:57 ET | 500 | 0.62501 |
| 01:00 ET | 100 | 0.625 |
| 01:02 ET | 333 | 0.625 |
| 01:06 ET | 100 | 0.625 |
| 01:09 ET | 5900 | 0.625 |
| 01:11 ET | 696 | 0.63 |
| 01:15 ET | 6623 | 0.64 |
| 01:18 ET | 1086 | 0.632501 |
| 01:22 ET | 500 | 0.6251 |
| 01:24 ET | 260 | 0.625 |
| 01:26 ET | 2000 | 0.63 |
| 01:27 ET | 4298 | 0.63 |
| 01:29 ET | 1800 | 0.625101 |
| 01:33 ET | 2153 | 0.64 |
| 01:36 ET | 100 | 0.6326 |
| 01:44 ET | 400 | 0.6326 |
| 01:45 ET | 166 | 0.6325 |
| 01:47 ET | 1270 | 0.635 |
| 01:49 ET | 945 | 0.635 |
| 01:51 ET | 1050 | 0.635 |
| 01:54 ET | 1400 | 0.632 |
| 01:56 ET | 100 | 0.6399 |
| 02:14 ET | 100 | 0.6331 |
| 02:18 ET | 1000 | 0.632 |
| 02:23 ET | 100 | 0.634 |
| 02:25 ET | 5908 | 0.636 |
| 02:27 ET | 481 | 0.635951 |
| 02:34 ET | 322 | 0.632 |
| 02:36 ET | 380 | 0.632 |
| 02:38 ET | 794 | 0.632 |
| 02:41 ET | 100 | 0.635949 |
| 02:48 ET | 500 | 0.632 |
| 02:56 ET | 10323 | 0.6399 |
| 02:57 ET | 63310 | 0.625 |
| 02:59 ET | 3957 | 0.62 |
| 03:06 ET | 15675 | 0.6203 |
| 03:08 ET | 406 | 0.6204 |
| 03:10 ET | 626 | 0.6214 |
| 03:15 ET | 500 | 0.6202 |
| 03:21 ET | 6269 | 0.6154 |
| 03:24 ET | 200 | 0.6188 |
| 03:32 ET | 1897 | 0.625 |
| 03:33 ET | 1765 | 0.6113 |
| 03:35 ET | 100 | 0.618 |
| 03:37 ET | 227 | 0.6101 |
| 03:42 ET | 400 | 0.613 |
| 03:44 ET | 12500 | 0.62 |
| 03:46 ET | 200 | 0.6201 |
| 03:48 ET | 7343 | 0.6249 |
| 04:00 ET | 3380 | 0.6298 |
Nov 12, 2024
TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex(R) Grant, from 9:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
9:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
Oct 30, 2024
TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements, from 8:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
8:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
Oct 25, 2024
DJ TC BioPharm Isn't at Risk of Delisting, Company Says, from 1:41PM ET on Friday Oct 25, 2024 by Dow Jones
1:41PM ET on Friday Oct 25, 2024 by Dow JonesTCBP Responds to False Social Media Claim, from 9:45AM ET on Friday Oct 25, 2024 by Dow Jones
9:45AM ET on Friday Oct 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
TC Biopharm (Holdings) PLC | 332.9K | 0.0x | --- |
Bellerophon Therapeutics Inc | 464.8K | -0.1x | --- |
Capstone Therapeutics Corp | 504.4K | -0.5x | --- |
LadRx Corp | 365.0K | -0.1x | --- |
GlobeStar Therapeutics Corp | 348.9K | -0.1x | --- |
RespireRx Pharmaceuticals Inc | 292.3K | -0.1x | --- |
Company Information
TC BioPharm (Holdings) plc, formerly TC BioPharm (Holdings) Limited, is a clinical-stage biopharmaceutical company. The Company is focused on developing immunotherapy products that are based on its allogeneic gamma delta T (GD-T) cell platform. Harnessing the innate ability of GD-Ts, the Company has developed a range of clinical-stage cell therapies designed to combat identified cancers and viral infections. In addition to unmodified allogenic GD-Ts for treatment of blood cancers, it is also developing a range of genetically modified chimeric antigen receptor modified T cell (CAR-T) products for treatment of solid cancers. The Company’s pipeline includes OmnImmune, ImmuniStim, TCB009, and TCB005/TCB006. OmnImmune is an allogeneic unmodified GD-T (GD-T2) cell product, used for the treatment of Acute Myeloid Leukaemia (AML). ImmuniStim is used for the treatment of coronavirus disease (COVID-19). TCB009 is developing GD-T2 based cell therapies.
Contact Information
- Headquarters
- Maxim 1, 2 Parklands Way, Holytown, United Kingdom ML1 4WR
- Phone
- 141-433-7557
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $332.8K |
|---|---|
Revenue (TTM) | --- |
Shares Outstanding | 2.6K |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | --- |
Book Value | $32.86 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
